Drug interaction study for older people with HIV
Part of Cancer, Heart & circulation, Hormones & metabolism, Immune system & allergy, Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how other medicines you take for conditions like high blood pressure, diabetes, or cholesterol might interact with your HIV medication (Biktarvy) if you are 60 or older. The goal is to learn how to better manage your overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have HIV and are currently taking a medication called Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide).
- You have at least one other health condition (like high blood pressure, diabetes, or cholesterol) for which you take medication.
- You have never had a test showing that your HIV is resistant to the medicines in Biktarvy.
- You do not have a serious acute infection right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with well-controlled HIV who are planning to switch to a long-acting HIV medicine given as injections. It may help researchers understand how this approach works for people already stable on current treatment.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
This study tests a new oral drug to see if it is safe and how the body processes it. It is for healthy adults without HIV, and results will help determine if the drug could be used for HIV prevention in the future.
This study looks at how well women with HIV stay in care while taking the medication Biktarvy (a combination of three drugs in one pill). It aims to understand their health outcomes and support better care.
This study looks at where HIV hides in the body (called the viral reservoir) in men whose HIV is well controlled with Biktarvy. Researchers want to see how the levels of HIV medicines in the body relate to these hidden virus cells, which may help improve future treatments.
This study tests a new HIV medication (GS-3242) combined with lenacapavir against your current Biktarvy regimen. Both are all-oral treatments for people whose HIV is well-controlled.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.